-
Amantadine and phenytoin: patent protected cases of drug repositioning
Jan M. Keppel Hesselink
Research Article: Clinical Investigation
-
Amantadine and phenytoin: patent protected cases of drug repositioning
Jan M. Keppel Hesselink
Research Article: Clinical Investigation
-
Amantadine and phenytoin: patent protected cases of drug repositioning
Jan M. Keppel Hesselink
Research Article: Clinical Investigation
-
Amantadine and phenytoin: patent protected cases of drug repositioning
Jan M. Keppel Hesselink
Research Article: Clinical Investigation
-
Amantadine and phenytoin: patent protected cases of drug repositioning
Jan M. Keppel Hesselink
Research Article: Clinical Investigation
-
Amantadine and phenytoin: patent protected cases of drug repositioning
Jan M. Keppel Hesselink
Research Article: Clinical Investigation
-
Amantadine and phenytoin: patent protected cases of drug repositioning
Jan M. Keppel Hesselink
Research Article: Clinical Investigation
-
Amantadine and phenytoin: patent protected cases of drug repositioning
Jan M. Keppel Hesselink
Research Article: Clinical Investigation
-
Ivabradine for the treatment of heart failure
Lynn Elzir, Eileen OMeara, Simon de Denus & Jean-Claude Tardif
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ivabradine for the treatment of heart failure
Lynn Elzir, Eileen OMeara, Simon de Denus & Jean-Claude Tardif
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ivabradine for the treatment of heart failure
Lynn Elzir, Eileen OMeara, Simon de Denus & Jean-Claude Tardif
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ivabradine for the treatment of heart failure
Lynn Elzir, Eileen OMeara, Simon de Denus & Jean-Claude Tardif
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ivabradine for the treatment of heart failure
Lynn Elzir, Eileen OMeara, Simon de Denus & Jean-Claude Tardif
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ivabradine for the treatment of heart failure
Lynn Elzir, Eileen OMeara, Simon de Denus & Jean-Claude Tardif
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ivabradine for the treatment of heart failure
Lynn Elzir, Eileen OMeara, Simon de Denus & Jean-Claude Tardif
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ivabradine for the treatment of heart failure
Lynn Elzir, Eileen OMeara, Simon de Denus & Jean-Claude Tardif
Review: Clinical Trail Outcomes: Clinical Investigation
-
The handling of missing data in clinical trials
Michael G Kenward
Clinical Trail Methodology: Clinical Investigation
-
The handling of missing data in clinical trials
Michael G Kenward
Clinical Trail Methodology: Clinical Investigation
-
The handling of missing data in clinical trials
Michael G Kenward
Clinical Trail Methodology: Clinical Investigation
-
The handling of missing data in clinical trials
Michael G Kenward
Clinical Trail Methodology: Clinical Investigation
-
The handling of missing data in clinical trials
Michael G Kenward
Clinical Trail Methodology: Clinical Investigation
-
The handling of missing data in clinical trials
Michael G Kenward
Clinical Trail Methodology: Clinical Investigation
-
The handling of missing data in clinical trials
Michael G Kenward
Clinical Trail Methodology: Clinical Investigation
-
The handling of missing data in clinical trials
Michael G Kenward
Clinical Trail Methodology: Clinical Investigation
-
Clinical evidence of the role of edoxaban in anticoagulation
Elena Fortuny ,Jose Zamorano
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence of the role of edoxaban in anticoagulation
Elena Fortuny ,Jose Zamorano
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence of the role of edoxaban in anticoagulation
Elena Fortuny ,Jose Zamorano
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence of the role of edoxaban in anticoagulation
Elena Fortuny ,Jose Zamorano
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence of the role of edoxaban in anticoagulation
Elena Fortuny ,Jose Zamorano
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence of the role of edoxaban in anticoagulation
Elena Fortuny ,Jose Zamorano
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence of the role of edoxaban in anticoagulation
Elena Fortuny ,Jose Zamorano
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence of the role of edoxaban in anticoagulation
Elena Fortuny ,Jose Zamorano
Review: Clinical Trail Outcomes: Clinical Investigation
-
Phase III study shows promising results for personalized medicine in advanced melanoma
News and Views: Clinical Investigation
-
Phase III study shows promising results for personalized medicine in advanced melanoma
News and Views: Clinical Investigation
-
Phase III study shows promising results for personalized medicine in advanced melanoma
News and Views: Clinical Investigation
-
Phase III study shows promising results for personalized medicine in advanced melanoma
News and Views: Clinical Investigation
-
Phase III study shows promising results for personalized medicine in advanced melanoma
News and Views: Clinical Investigation
-
Phase III study shows promising results for personalized medicine in advanced melanoma
News and Views: Clinical Investigation
-
Phase III study shows promising results for personalized medicine in advanced melanoma
News and Views: Clinical Investigation
-
Phase III study shows promising results for personalized medicine in advanced melanoma
News and Views: Clinical Investigation